Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
Yuqian Liao,1,* Yulu Liao,2,* Jun Li,2 Junyu Li,2 Ying Fan,3 Binghe Xu3 1Department of Medical Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People’s Republic of China; 2Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People&rsquo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-09-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/polymorphisms-in-aurka-and-aurkb-are-associated-with-the-survival-of-t-peer-reviewed-article-CMAR |
| _version_ | 1819068459026219008 |
|---|---|
| author | Liao Y Liao Y Li J Li J Fan Y Xu B |
| author_facet | Liao Y Liao Y Li J Li J Fan Y Xu B |
| author_sort | Liao Y |
| collection | DOAJ |
| description | Yuqian Liao,1,* Yulu Liao,2,* Jun Li,2 Junyu Li,2 Ying Fan,3 Binghe Xu3 1Department of Medical Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People’s Republic of China; 2Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People’s Republic of China; 3Department of Medical Oncology, Cancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of China *These authors contributed equally to this work Purpose: Triple-negative breast cancer (TNBC) is more than a single disease. Identifying biomarkers to further subdivide TNBC patients with distinct outcome is of great importance. It has been reported that single-nucleotide polymorphisms (SNPs) in Aurora kinase A (AURKA) or Aurora kinase B (AURKB) are associated with the risk and survival of several cancers. But till now, there is no research about these polymorphisms in TNBC patients. Materials and methods: In this study, we investigated the association between polymorphisms in AURKA or AURKB gene and prognosis of TNBC patients treated with taxane-based adjuvant chemotherapy. A total of 273 TNBC patients were enrolled. Haploview 4.2 software was used to identify Tag SNPs. Genotyping was conducted using the MassARRAY MALDI-TOF system. Results: We found that AURKA rs6099128 GG genotype carriers had significantly worse overall survival (OS) than TT+ TG genotype carriers (P = 0.003, HR = 12.499, 95% CI = 2.357–66.298). AURKB rs11651993 TT genotype carriers had better disease-free survival (DFS) than TC + CC genotype carriers (P = 0.018, HR = 1.876, 95% CI = 1.116–3.154). AURKB rs2289590 CC genotype carriers had worse DFS than CA + AA genotype carriers (P = 0.021, HR = 0.536, 95% CI = 0.315–0.912). After subgroup analysis, rs11651993 TC + CC genotype predicted worse DFS in subgroups of age ≤ 50, post-menopausal, grade unknown (UK), tumor size >2 cm, and lymph node negative. Rs2289590 CA + AA genotype could predict favorable DFS in pre-menopausal, grade 3 and lymph node-positive patients. Conclusion: We first demonstrated that polymorphisms in AURKA or AURKB gene might predict the OS or DFS of TNBC patients treated with taxane-based adjuvant chemotherapy. Keywords: Aurora kinase, TNBC, polymorphism, prognosis |
| first_indexed | 2024-12-21T16:34:29Z |
| format | Article |
| id | doaj.art-86834decef8c46ae8c347be60ee2ebb3 |
| institution | Directory Open Access Journal |
| issn | 1179-1322 |
| language | English |
| last_indexed | 2024-12-21T16:34:29Z |
| publishDate | 2018-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Cancer Management and Research |
| spelling | doaj.art-86834decef8c46ae8c347be60ee2ebb32022-12-21T18:57:15ZengDove Medical PressCancer Management and Research1179-13222018-09-01Volume 103801380840780Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapyLiao YLiao YLi JLi JFan YXu BYuqian Liao,1,* Yulu Liao,2,* Jun Li,2 Junyu Li,2 Ying Fan,3 Binghe Xu3 1Department of Medical Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People’s Republic of China; 2Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People’s Republic of China; 3Department of Medical Oncology, Cancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of China *These authors contributed equally to this work Purpose: Triple-negative breast cancer (TNBC) is more than a single disease. Identifying biomarkers to further subdivide TNBC patients with distinct outcome is of great importance. It has been reported that single-nucleotide polymorphisms (SNPs) in Aurora kinase A (AURKA) or Aurora kinase B (AURKB) are associated with the risk and survival of several cancers. But till now, there is no research about these polymorphisms in TNBC patients. Materials and methods: In this study, we investigated the association between polymorphisms in AURKA or AURKB gene and prognosis of TNBC patients treated with taxane-based adjuvant chemotherapy. A total of 273 TNBC patients were enrolled. Haploview 4.2 software was used to identify Tag SNPs. Genotyping was conducted using the MassARRAY MALDI-TOF system. Results: We found that AURKA rs6099128 GG genotype carriers had significantly worse overall survival (OS) than TT+ TG genotype carriers (P = 0.003, HR = 12.499, 95% CI = 2.357–66.298). AURKB rs11651993 TT genotype carriers had better disease-free survival (DFS) than TC + CC genotype carriers (P = 0.018, HR = 1.876, 95% CI = 1.116–3.154). AURKB rs2289590 CC genotype carriers had worse DFS than CA + AA genotype carriers (P = 0.021, HR = 0.536, 95% CI = 0.315–0.912). After subgroup analysis, rs11651993 TC + CC genotype predicted worse DFS in subgroups of age ≤ 50, post-menopausal, grade unknown (UK), tumor size >2 cm, and lymph node negative. Rs2289590 CA + AA genotype could predict favorable DFS in pre-menopausal, grade 3 and lymph node-positive patients. Conclusion: We first demonstrated that polymorphisms in AURKA or AURKB gene might predict the OS or DFS of TNBC patients treated with taxane-based adjuvant chemotherapy. Keywords: Aurora kinase, TNBC, polymorphism, prognosishttps://www.dovepress.com/polymorphisms-in-aurka-and-aurkb-are-associated-with-the-survival-of-t-peer-reviewed-article-CMARAurora kinaseTNBCpolymorphismsurvival |
| spellingShingle | Liao Y Liao Y Li J Li J Fan Y Xu B Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy Cancer Management and Research Aurora kinase TNBC polymorphism survival |
| title | Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy |
| title_full | Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy |
| title_fullStr | Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy |
| title_full_unstemmed | Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy |
| title_short | Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy |
| title_sort | polymorphisms in aurka and aurkb are associated with the survival of triple negative breast cancer patients treated with taxane based adjuvant chemotherapy |
| topic | Aurora kinase TNBC polymorphism survival |
| url | https://www.dovepress.com/polymorphisms-in-aurka-and-aurkb-are-associated-with-the-survival-of-t-peer-reviewed-article-CMAR |
| work_keys_str_mv | AT liaoy polymorphismsinaurkaandaurkbareassociatedwiththesurvivaloftriplenegativebreastcancerpatientstreatedwithtaxanebasedadjuvantchemotherapy AT liaoy polymorphismsinaurkaandaurkbareassociatedwiththesurvivaloftriplenegativebreastcancerpatientstreatedwithtaxanebasedadjuvantchemotherapy AT lij polymorphismsinaurkaandaurkbareassociatedwiththesurvivaloftriplenegativebreastcancerpatientstreatedwithtaxanebasedadjuvantchemotherapy AT lij polymorphismsinaurkaandaurkbareassociatedwiththesurvivaloftriplenegativebreastcancerpatientstreatedwithtaxanebasedadjuvantchemotherapy AT fany polymorphismsinaurkaandaurkbareassociatedwiththesurvivaloftriplenegativebreastcancerpatientstreatedwithtaxanebasedadjuvantchemotherapy AT xub polymorphismsinaurkaandaurkbareassociatedwiththesurvivaloftriplenegativebreastcancerpatientstreatedwithtaxanebasedadjuvantchemotherapy |